25.48
+1.28 (+5.29%)
EUR · F
52-week range
11.82
44.72
Trading at 42% of the 52-week range
Market Cap
5.94B
P/E Ratio
0.00
Forward P/E
78.74
Book Value
1.24
Div. Yield
N/A
% Institutions
70.99%
% Insiders
4.95%

1 Year

-48.6%

3 Year

+337.8%

10 Year

+192.9%
Description

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Actions

Add an action for 82W.F, or sign in to see your action list.

Company Information

▼
Company Name
HIMS+HERS HERS A DL-0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
F
Currency: EUR
Full Time Employees: 2,442
Phone: 415 851 0195
Website: hims.com
Fiscal Year End: December
Description:

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Address:

2269 Chestnut Street, San Francisco, CA, United States, 94123

People

▼

Directors & Officers

Name Title Year Born
Mr. Andrew Dudum Co-Founder, Chairman & CEO 1988
Mr. Mike Chi Chief Operating Officer 1980
Mr. Mohamed ElShenawy Chief Technology Officer 1975
Ms. Soleil Teubner Boughton J.D. Chief Legal Officer & Corporate Secretary 1978
Dr. Patrick Carroll M.D. Global Chief Medical Officer 1958
Ms. Deborah M. Autor J.D. Chief Policy Officer & Director 1967
Dr. Peter Stahl M.D. Senior Vice President of Men's Reproductive & Sexual Health NA
Dr. Daniel Lieberman M.D. Senior Vice President of Mental Health NA
Dr. Craig Primack M.D. Senior Vice President of Weight Loss NA
Mr. Dan Kenger Chief Design Officer NA

Financial Highlights

▼
Market Cap: $5.94B
EBITDA: $-10.18M
PEG Ratio: $2.76
Book Value: $1.24
Earnings/Share: $-0.52
Profit Margin: -5.51%
Operating Margin: -12.75%
ROA (TTM): -2.21%
ROE (TTM): -32.03%
Revenue (TTM): $2.58B
Revenue/Share (TTM): $11.29
Earnings Growth (YOY): -17.40%
Revenue Growth (YOY): 38.20%

Valuation Metrics

Enterprise Value: $6.40B
Trailing P/E: 0.00
Forward P/E: 78.74

Shares Statistics

Shares Outstanding: 224.94M
Shares Float: 213.75M
% Insiders: 4.95%
% Institutions: 70.99%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$2.35B
Cost of Goods Sold
adjust
$-614.26M
Gross Profit
subtotal
$1.73B
SG&A
adjust
$-1.19B
R&D
adjust
$-149.30M
Other Operating Expense
adjust
$-900.70M
Operating Income
subtotal
$105.61M
Other / Non-Operating Items
adjust
$22.75M
Net Income
subtotal
$128.37M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about 82W.F!